Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
American Journal of Clinical Oncology|June 1, 1992
Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology AssociationD J Schifeling, D V Jackson, P J Zekan, et al.Medical and Pediatric Oncology|January 1, 1986
Ara-C syndrome during low-dose continuous infusion therapyB L Powell, P J Zekan, H B Muss, et al.The American Journal of Medicine|June 1, 1988
Amelioration of vincristine neurotoxicity by glutamic acidD V Jackson, H B Wells, J N Atkins, et al.Medical and Pediatric Oncology|January 1, 1989
Mitoxantrone and high-dose ara-C in refractory malignancies: a phase I trialW J Smith, H B Muss, R L Capizzi, et al.Investigational New Drugs|July 1, 1989
Phase I study of vincristine and escalating doses of etoposideD V Jackson, J M Cruz, P J Zekan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administrationH B Muss, J J Costanzi, R Leavitt, et al.Cancer Investigation|January 1, 1987
Vinblastine infusion in non-Hodgkin's lymphomas: lack of total cross-resistance with vincristineD V Jackson, C L Spurr, M E Caponera, et al.Surgery, Gynecology & Obstetrics|April 1, 1989
Chemoinfusion of the hepatic artery for metastases to the liverJ M Sterchi, F Richards, D R White, et al.Investigational New Drugs|January 1, 1986
Recombinant gamma interferon in advanced breast cancer: a phase II trialH B Muss, M Caponera, P J Zekan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology AssociationD V Jackson, P J Zekan, R D Caldwell, et al.Pageof 2